| Home > 106th Congressional Bills > H.R. 541 (ih) To amend the Fair Labor Standards Act of 1938 to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex, and for other purposes. [Introduced in House] ...
H.R. 541 (ih) To amend the Fair Labor Standards Act of 1938 to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex, and for other purposes. [Introduced in House] ...
106th CONGRESS 2d Session H. R. 5419 To amend the Public Health Service Act to establish a demonstration project at the National Cancer Institute to provide funding for research concerning the prevention, diagnosis, treatment, and cure for cancer. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 6, 2000 Ms. Pryce of Ohio (for herself and Mrs. Capps) introduced the following bill; which was referred to the Committee on Commerce _______________________________________________________________________ A BILL To amend the Public Health Service Act to establish a demonstration project at the National Cancer Institute to provide funding for research concerning the prevention, diagnosis, treatment, and cure for cancer. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Millennium Cancer Research Act''. SEC. 2. NATIONAL CANCER INSTITUTE DEMONSTRATION PROGRAM. Subpart 1 of part C of title IV of the Public Health Service Act (42 U.S.C. 285 et seq.) is amended-- (1) by redesignating section 417B as section 417C; and (2) by inserting after section 417A, the following: ``SEC. 417B. DEMONSTRATION PROJECT FOR MORE EFFECTIVE RESEARCH. ``(a) Establishment.--The Director of the Institute shall establish a demonstration project under which the Institute shall provide for the conduct of research through an infrastructure that fosters scientific creativity and increases fundamental biological understanding leading to the prevention, diagnosis, treatment, and cure of cancer. ``(b) Authorized Activities.--Under the demonstration project under subsection (a), the Director of the Institute shall-- ``(1) establish efficient and cost-effective research processes and management practices that eliminate redundant business practices and provide for ongoing and rigorous oversight to ensure both quality management and quality science; ``(2) develop a management plan that outlines, in a clear and concise manner, the-- ``(A) improvements that will be made under the demonstration project in the research practices of the Institute; ``(B) benefits to be achieved through such improvements; ``(C) required modifications to existing rules and regulations that are necessary to carry out the management plan; and ``(D) processes that will be used to implement the required modifications; ``(3) establish formal review, oversight, and management control procedures to ensure the effective implementation and execution of the management plan; and ``(4) carry out the demonstration project using amounts provided for the Institute under the annual appropriations process. ``(c) Authority of Director.--To carry out the demonstration project under this section, the Director of the Institute shall have the following authority: ``(1) Human resources system.--The Director of the Institute shall, using the authority provided to the Director under this Act, as well as authorities under section 207(f), carry out a 5-year pilot program under which the Director shall establish a comprehensive competitive human resources system that complies with existing guidelines under title 42, Code of Federal Regulations, and applicable affirmative action requirements. In establishing such system the Director shall-- ``(A) appoint individuals to provide services in furtherance of the mission of the Institute; ``(B) obtain the services of experts or consultants as determined necessary by the Director notwithstanding section 413(b)(5); ``(C) have the authority, notwithstanding limitations on full time equivalent personnel, to hire appropriate personnel, subject to the availability of funds; and ``(D) have the authority, notwithstanding limitations on cost-sharing or duration, to execute Intergovernmental Personnel Act Agreements under terms that are mutually agreeable to the Director of the Institute and the loaning or receiving employer. ``(2) Transactions.--The Director of the Institute may enter into transactions (other than contracts, cooperative agreements, and grants) to carry out basic, applied, and advanced research projects. The authority provided under this paragraph shall be in addition to the authority provided under sections 405 and 413 to use contracts, cooperative agreements, and grants in carrying out such projects. ``(3) High impact, innovative research in cancer.-- ``(A) In general.--The Director of the Institute shall establish a program to encourage high impact, cutting edge research that will lead to future progress against cancer. Such program shall be designed to enable the Director to undertake research projects with maximum flexibility and speed. The requirements of section 303 of the Federal Property and Administrative Services Act of 1949 (41 U.S.C. 253), section 8 of the Small Business Act (15 U.S.C. 637e), section 18 of the Office of Federal Procurement Policy Act (41 U.S.C. 416), and sections 405 and 492 of this Act, and any regulations promulgated under such provisions of law, shall be waived with respect to critical research projects undertaken under the program authorized by this paragraph. Such program shall be designed to enable the Director, as rapidly as practicable to-- ``(i) select new initiatives, after an expeditious peer review with requisite expertise, for further development and research; ``(ii) identify partners and collaborators for such initiatives; ``(iii) select the appropriate funding mechanism for such initiatives; ``(iv) reprogram up to 2 percent of the amounts appropriated to the National Cancer Institute to support such initiatives and research; and ``(v) make awards with respect to new initiatives and research. ``(B) Report.--The Director shall annually submit a report to Congress that identifies those initiatives that were funded in the year for which the report is being submitted under subparagraph (A). ``(C) Use of experts.--In carrying out this paragraph, the Director of the Institute may, notwithstanding the Federal Advisory Committee Act (5 U.S.C. App.), convene groups, that may be composed of both Federal and non-Federal employees, to obtain consensus advice or recommendations. ``(4) Funding.--The Director of the Institute may redirect within the National Cancer Institute, as necessary in a fiscal year, not to exceed 5 percent of the amount appropriated for the National Cancer Institute for such fiscal year. Such redirected funds shall be used for new, high priority initiatives. ``(5) Grants.--Notwithstanding the limitation under section 405(b)(2)(B), and any regulations implementing such provision, the Director of the Institute may award grants and cooperative agreements to carry out initiatives under this subsection. The Director may not award a grant or cooperative agreement in an amount to exceed $300,000 without obtaining a second level review by the National Cancer Advisory Board. ``(6) Compensation.--Notwithstanding any other provision of law, the Director of the Institute shall make a salary determination for senior contract research scientists employed at the Federally Funded Research and Development Centers of the Institute consistent with the salary levels applicable for staff of the Institute under titles 5 and 38, United States Code, and under this Act. ``(7) Other agreements.--Notwithstanding the limitations contained in section 413(b)(6) and the Public Buildings Act of 1959 (40 U.S.C. 601 et seq.), the Director of the Institute may enter into agreements that maximize the operations and efficiency of the National Cancer Institute in fulfilling its mission. ``(d) Report.--The Director of the Institute shall annually prepare and submit to the Director of the National Institutes of Health a report concerning those activities carried out under this section that the Director of the Institute determines may have a potential benefit for other research activities carried out by the National Institutes of Health. ``(e) Termination.--The authority provided under this section shall terminate on the date that is 5 years after the date of enactment of the Millennium Cancer Research Act.''. SEC. 3. CONFORMING AMENDMENT. Section 406(h)(2)(A) of the Public Health Service Act (42 U.S.C. 284a(h)(2)(A)) is amended-- (1) in clause (iii), by adding ``and'' at the end; (2) by striking clause (iv); and (3) by redesignating clause (v) as clause (iv). <all>
Other Popular 106th Congressional Bills Documents:
|GovRecords.org presents information on various agencies of the United States Government. Even though all information is believed to be credible and accurate, no guarantees are made on the complete accuracy of our government records archive. Care should be taken to verify the information presented by responsible parties. Please see our reference page for congressional, presidential, and judicial branch contact information. GovRecords.org values visitor privacy. Please see the privacy page for more information.|
Supreme Court Decisions
104th Congressional Documents
105th Congressional Documents
106th Congressional Documents
107th Congressional Documents
108th Congressional Documents
1994 Presidential Documents